1887

Abstract

The haemagglutinin—esterase gene (HE) of bovine coronavirus (BCV) encodes a major viral membrane glycoprotein that elicits BCV-neutralizing antibodies. The BCV HE gene was cloned into a human adenovirus serotype 5 (Ad5) transfer vector in place of early transcription region 3, and a helper-independent recombinant virus was constructed by rescue of the transcription unit by homologous recombination between the vector and Ad5 genomic DNA. The BCV HE polypeptide expressed by this recombinant Ad was characterized and . A 65K polypeptide was identified using an anti-BCV antibody in both human (293) and bovine (MDBK) cells infected with the recombinant Ad. In the absence of a reducing agent, migration of the 65K polypeptide was shifted to 130K, indicating that the recombinant HE polypeptide existed in a dimeric form. The HE polypeptide was glycosylated, as demonstrated by labelling with [H]glucosamine, and was immunoreactive with three distinct groups of conformation-specific anti-HE monoclonal antibodies (MAbs). Cells infected with recombinant Ad expressing BCV HE exhibited both haemadsorption activity and acetylesterase activity. In addition, the anti-HE group A MAbs HC10-5 and KD9-40 inhibited both the haemadsorption activity and esterase activity of the recombinant HE polypeptide, suggesting that the antigenic domain responsible for BCV neutralization may overlap (or is closely associated with) the domain(s) responsible for haemagglutination and/or acetylesterase activities. When mice were inoculated intraperitoneally with live recombinant Ad, a significant level of BCV-neutralizing HE-specific antibody was induced. These results indicate that the recombinant Ad replicates and directs the synthesis of the BCV HE polypeptide .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-10-2591
1992-10-01
2022-11-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/10/JV0730102591.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-10-2591&mimeType=html&fmt=ahah

References

  1. Aiello L., Guilfoyle R., Huebner K., Weinmann T. 1979; Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells HEK-Ad5 and 293 cells. Virology 94:460–469
    [Google Scholar]
  2. Berk A. J., Lee F., Harrison T., Williams J., Sharp P. A. 1979; Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell 17:935–944
    [Google Scholar]
  3. Berkner K. K. 1988; Development of adenovirus vectors for the expression of heterologous genes. Bio/Technology 6:616–629
    [Google Scholar]
  4. Berkner K. K., Sharp P. A. 1983; Generation of adenovirus by transfection of plasmids. Nucleic Acids Research 11:6003–6020
    [Google Scholar]
  5. Boursnell M. E. G., Brown T. D. K., Foulds I. J., Green P. F., Tomley F. M., Binns M. M. 1987; Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. Journal of General Virology 68:57–77
    [Google Scholar]
  6. Callebaut P. E., Pensaert M. B. 1980; Characterization and isolation of structural polypeptides in haemagglutinating encephalomyelitis virus. Journal of General Virology 48:193–204
    [Google Scholar]
  7. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. 1982; Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119:358–371
    [Google Scholar]
  8. Couch R. B., Chanock R. M., Cate T. R., Lang D. J., Knight B., Huebner R. J. 1963; Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. American Review of Respiratory Diseases 88:394–403
    [Google Scholar]
  9. De Groots R. J., van Leen R. W., Dalderup M. J. H., Vennema H., Horzinek M. C., Spaan W. 1989; Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology 171:493–502
    [Google Scholar]
  10. Deregt D., Babiuk L. A. 1987; Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology 161:410–420
    [Google Scholar]
  11. Deregt D., Sabara M., Babiuk L. A. 1987; Structural proteins of bovine coronavirus and their intracellular processing. Journal of General Virology 68:2863–2877
    [Google Scholar]
  12. Deregt D., Gifford G. A., Ijaz M. K., Watts T. C., Gilchrist J. E., Haines D. M., Babiuk L. A. 1989; Monoclonal antibodies to bovine coronavirus glycoproteins E2 and E3: demonstration of in vivo virus-neutralizing activity. Journal of General Virology 70:993–998
    [Google Scholar]
  13. Garwes D. J., Reynolds D. J. 1981; The polypeptide structure of canine coronavirus and its relationship to porcine transmissible gastroenteritis virus. Journal of General Virology 52:153–157
    [Google Scholar]
  14. Ginsberg H. S. 1984 The Adenoviruses New York: Plenum Press;
    [Google Scholar]
  15. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S. M., Chanock R. M., Prince G. A. 1989; Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of Sciences, U.S.A. 86:3823–3827
    [Google Scholar]
  16. Gooding L. R., Elmore L. W., Tollefson A. E., Brady H. A., Wold W. S. M. 1988; A 14, 700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumour necrosis factor. Cell 53:341–346
    [Google Scholar]
  17. Gooding L. R., Ranheim T. S., Tollefson A. E., Aquino L., Duerksen-Hughes P., Horton T. M., Wold W. S. M. 1991; The 10, 400- and 14, 500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumour necrosis factor. Journal of Virology 65:4114–4123
    [Google Scholar]
  18. Graham F. L. 1990; Adenoviruses as expression vectors and recombinant vaccines. Trends in Biotechnology 8:85–87
    [Google Scholar]
  19. Graham F. L., Prevec L. 1991a; Manipulation of adenovirus vectors. Methods in Molecular Biology 7:109–128
    [Google Scholar]
  20. Graham F. L., Prevec L. 1991b; Adenovirus based expression vectors and recombinant vaccines. In Vaccines: New Approaches to Immunological Problems Edited by Ellis R. W. Oxford: Butter-worth-Heinemann; (in press)
    [Google Scholar]
  21. Graham F. L., van der Eb A. J. 1973; A new technique for the assay of infectivity of adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
  22. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus 5. Journal of General Virology 36:59–72
    [Google Scholar]
  23. Green M., Wold W. S. M. 1979; Human adenovirus. Growth, purification and transfection assays. Methods in Enzymology 58:425–435
    [Google Scholar]
  24. Haj-Ahmad Y., Graham F. L. 1986; Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. Journal of Virology 57:267–274
    [Google Scholar]
  25. Hogue B. G., Brian D. A. 1986; Structural proteins of human respiratory coronavirus OC43. Virus Research 5:131–144
    [Google Scholar]
  26. King B., Brian D. A. 1982; Bovine coronavirus structural proteins. Journal of Virology 42:700–707
    [Google Scholar]
  27. King B., Potts B., Brian D. A. 1985; Bovine coronavirus hemagglutinin protein. Virus Research 2:53–59
    [Google Scholar]
  28. Kvist S., Ostberg L., Persson H., Philipson L., Peterson P. A. 1978; Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proceedings of the National Academy of Sciences, U.S.A. 75:5674–5678
    [Google Scholar]
  29. Luytjes W., Bredenbeck A., Noten M., Horzinek M. C., Spaan W. 1988; Sequence of mouse hepatitis virus A59 mRNA 2: indication for RNA recombination between coronaviruses and influenza C virus. Virology 166:415–422
    [Google Scholar]
  30. MacNaughton M. R., Davies H. A., Nermut M. V. 1978; Ribonucleoprotein-like structures from coronavirus particles. Journal of General Virology 39:545–549
    [Google Scholar]
  31. Makino S., Lai M. M. C. 1989; Evolution of the 5′-end of genomic RNA of murine coronavirus during passages in vitro . Virology 169:227–232
    [Google Scholar]
  32. Mason B. B., Davis A. R., Bhat B. M., Chengalvana M., Lubeck M. D., Zandle Z., Kostek B., Cholodofsky S., Dheer S., Molnar-Kimber K., Mizutani S., Hung P. 1990; Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Virology 177:452–461
    [Google Scholar]
  33. Morin J. E., Lubeck M. D., Barton J. E., Conley A. J., Davis A. R., Hung P. P. 1987; Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proceedings of the National Academy of Sciences, U.S.A. 84:4626–4630
    [Google Scholar]
  34. Nakada S., Creager R. S., Krystal M., Aaronson R. P., Palese P. 1984; Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins. Journal of Virology 50:118–124
    [Google Scholar]
  35. Paabo S., Bhat B. M., Wold W. S. M., Peterson P. A. 1987; A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50:311–317
    [Google Scholar]
  36. Parker M. D., Cox G. J., Deregt D., Fitzpatrick D. R., Babiuk L. A. 1989; Cloning and in vitro expression of the gene for the E3 haemagglutinin glycoprotein of bovine coronavirus. Journal of General Virology 70:155–164
    [Google Scholar]
  37. Parker M. D., Yoo D., Babiuk L. A. 1990a; Expression and secretion of the bovine coronavirus hemagglutinin-esterase glycoprotein by insect cells infected with recombinant baculoviruses. Journal of Virology 64:1625–1629
    [Google Scholar]
  38. Parker M. D., Cox G. J., Yoo D., Fitzpatrick D. R., Babiuk L. A. 1990b; The hemagglutinin of bovine coronavirus exhibits significant similarity to the HE of type C influenza viruses. Advances in Experimental Medicine and Biology 276:297–303
    [Google Scholar]
  39. Piccini A., Paoletti E. 1988; Vaccinia: virus, vector, vaccine. Advances in Virus Research 34:43–64
    [Google Scholar]
  40. Prevec L., Schneider M., Rosenthal K. L., Belbeck L. W., Derbyshire J. B., Graham F. L. 1989; Use of human adenovirus-based vectors for antigen expression in animals. Journal of General Virology 70:429–434
    [Google Scholar]
  41. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  42. Rawle F. C., Tollefson A. E., Wold W. S. M., Gooding L. R. 1989; Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gpl9K but not E3 14.7K. Journal of Immunology 143:2031–2037
    [Google Scholar]
  43. Rottier P. J. M., Rose J. K. 1987; Coronavirus E1 glycoprotein expressed from cloned cDNA localized in the Golgi region. Journal of Virology 61:2042–2045
    [Google Scholar]
  44. Saito I., Oya Y., Yamamoto K., Yuasa T., Shimojo H. 1985; Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. Journal of Virology 54:711–719
    [Google Scholar]
  45. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  46. Schneider M., Graham F. L., Prevec L. 1989; Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. Journal of General Virology 70:417–427
    [Google Scholar]
  47. Shieh C. K., Lee H. J., Yokomori K., La Monica N., Makino S., Lai M. M. C. 1989; Identification of a new transcription initiation site and the corresponding functional gene 2b in murine coronavirus RNA genome. Journal of Virology 63:3729–3736
    [Google Scholar]
  48. Stern D. F., Sefton B. M. 1982; Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. Journal of Virology 44:804–812
    [Google Scholar]
  49. Sturman L. S., Ricard C. S., Holmes K. V. 1985; Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. Journal of Virology 56:904–911
    [Google Scholar]
  50. Tooze J., Tooze S., Warren G. 1984; Replication of coronavirus MHV-A59 in sac-cells: determination of the first site of budding of progeny virions. European Journal of Cell Biology 33:281–293
    [Google Scholar]
  51. Top F. H. Jr 1975; Control of adenovirus acute respiratory disease in U.S. army trainees. Yale Journal of Biology and Medicine 48:185–195
    [Google Scholar]
  52. Vlasak R., Luytjes W., Spaan W., Palese P. 1988a; Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those influenza C viruses. Proceedings of the National Academy of Sciences, U.S.A. 85:4526–4529
    [Google Scholar]
  53. Vlasak R., Luytjes W., Leider J., Spaan W., Palese P. 1988b; The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. Journal of Virology 62:4686–4690
    [Google Scholar]
  54. Wold W. S. M., Gooding L. R. 1989; Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Molecular Biology and Medicine 6:433–452
    [Google Scholar]
  55. Wold W. S. M., Gooding L. R. 1991; Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1–8
    [Google Scholar]
  56. Yokomori K., Banner L. R., Lai M. M. C. 1991; Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology 183:647–657
    [Google Scholar]
  57. Yoo D., Parker M. D., Babiuk L. A. 1991; The S2 subunit glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. Virology 180:395–399
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-10-2591
Loading
/content/journal/jgv/10.1099/0022-1317-73-10-2591
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error